In vitro Investigation of Metabolic Profiling of a Potent Topoisomerase Inhibitors Fluorescein Hydrazones (FLHs) in RLMs by LC-MS/MS
- 1 June 2017
- journal article
- Published by Elsevier in Journal of Chromatography B
- Vol. 1054, 27-35
Abstract
No abstract availableKeywords
Funding Information
- The National Plan for Science
This publication has 25 references indexed in Scilit:
- Liquid chromatographic high-throughput analysis of the new ultra-short acting hypnotic ‘HIE-124’ and its metabolite in mice serum using a monolithic silica columnThe Analyst, 2010
- DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial InhibitionChemical Reviews, 2009
- New ultra-short acting hypnotic: Synthesis, biological evaluation, and metabolic profile of ethyl 8-oxo-5,6,7,8-tetrahydro-thiazolo[3,2-a][1,3]diazepin-3-carboxylate (HIE-124)Bioorganic & Medicinal Chemistry Letters, 2008
- Direct determination of estriol 3‐ and 16‐glucuronides in pregnancy urine by column‐switching liquid chromatography with electrospray tandem mass spectrometryBiomedical Chromatography, 2003
- Tumor Cell Death Induced by Topoisomerase-Targeting DrugsAnnual Review of Pharmacology and Toxicology, 2001
- High-throughput screening approaches for investigating drug metabolism and pharmacokineticsXenobiotica, 2001
- High-Throughput Screening in Drug Metabolism and Pharmacokinetic Support of Drug DiscoveryAnnual Review of Pharmacology and Toxicology, 2000
- Inhibition and Induction of Cytochrome P450 and the Clinical ImplicationsClinical Pharmacokinetics, 1998
- Characterization of brimonidine metabolism with rat, rabbit, dog, monkey and human liver fractions and rabbit liver aldehyde oxidaseXenobiotica, 1996
- N‐Hydroxylation of dapsone by multiple enzymes of cytochrome P450: implications for inhibition of haemotoxicity.British Journal of Clinical Pharmacology, 1995